Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety Surveillance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02475356
What this trial is testing

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea

Who this might be right for
Menorrhagia, Dysmenorrhea
Bayer 601
Not applicableStudy completedNCT01789905
What this trial is testing

Tygacil Drug Use Investigation

Who this might be right for
Intra-Abdominal InfectionsSkin Disease, Infectious
Pfizer 116
Not applicableStudy completedNCT00293709
What this trial is testing

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

Who this might be right for
Arthritis, PsoriaticPsoriasisSkin Diseases, Papulosquamous
Pfizer 129
Not applicableWithdrawnNCT01203163
What this trial is testing

Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes

Who this might be right for
Esophageal CancerLung CancerBarrett's Esophagus
Pinnacle Biologics Inc.
Not applicableStudy completedNCT02093741
What this trial is testing

ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)

Who this might be right for
Hemophilia ACongenital Factor VIII (FVIII) Deficiency
Baxalta now part of Shire 65
Not applicableEnded earlyNCT02577913
What this trial is testing

European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception

Who this might be right for
Contraception
Center for Epidemiology and Health Research, Germany 2,281
Not applicableStudy completedNCT01078220
What this trial is testing

Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)

Who this might be right for
Human Papillomavirus Infection
Merck Sharp & Dohme LLC 189,629
Not applicableStudy completedNCT04460079
What this trial is testing

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Who this might be right for
Chemotherapy-induced Neutropenia
Cinnagen 654
Not applicableStudy completedNCT01243268
What this trial is testing

A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy

Who this might be right for
Hypertension
Boehringer Ingelheim 674
Not applicableStudy completedNCT00620516
What this trial is testing

Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 3,008
Not applicableStudy completedNCT01081717
What this trial is testing

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

Who this might be right for
Rheumatoid ArthritisArthritis, PsoriaticAnkylosing Spondylitis
Janssen Biotech, Inc. 1,064
Not applicableStudy completedNCT02162264
What this trial is testing

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice

Who this might be right for
Alzheimer's Disease
Eisai Co., Ltd. 8,662
Not applicableLooking for participantsNCT06073860
What this trial is testing

A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia

Who this might be right for
Myelodysplastic SyndromeBeta Thalassemia
Bristol-Myers Squibb 104
Post-approval studies (Phase 4)Looking for participantsNCT05515367
What this trial is testing

A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)

Who this might be right for
Chronic Kidney DiseasesAnemia of Chronic Kidney Disease
Zydus Lifesciences Limited 1,004
Not applicableStudy completedNCT04071405
What this trial is testing

Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients

Who this might be right for
Ulcerative Colitis
Pfizer 110
Not applicableStudy completedNCT01795105
What this trial is testing

ABF Tourette's Disorder Post Marketing Surveillance Study

Who this might be right for
Tourette's Disorder
Korea Otsuka Pharmaceutical Co., Ltd. 692
Not applicableStudy completedNCT02556905
What this trial is testing

Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea

Who this might be right for
Multiple Myeloma
Celgene 624
Not applicableStudy completedNCT02539082
What this trial is testing

The Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis

Who this might be right for
Plantar Fasciitis
Cellontech Co., Ltd. 60
Not applicableStudy completedNCT01037023
What this trial is testing

Regulatory Hycamtin(Oral) PMS

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 92
Not applicableStudy completedNCT01354990
What this trial is testing

A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 2,974
Next Page